(Q37570408)

21 August 2017

Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials (English)

1 reference

21 August 2017

phase I clinical trial

0 references

9

Alexia Iasonos

1 reference

21 August 2017

3

Mrinal M Gounder

1 reference

21 August 2017

David M Hyman

1

1 reference

21 August 2017

Anne A Eaton

2

1 reference

21 August 2017

Gary L Smith

4

1 reference

21 August 2017

Erika G Pamer

5

1 reference

21 August 2017

Martee L Hensley

6

1 reference

21 August 2017

David R Spriggs

7

1 reference

21 August 2017

Percy Ivy

8

1 reference

21 August 2017

language of work or name

English

0 references

publication date

13 January 2014

1 reference

Journal of Clinical Oncology

21 August 2017

1 reference

21 August 2017

32

1 reference

21 August 2017

6

1 reference

21 August 2017

519-526

1 reference

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

How to build and interpret a nomogram for cancer prognosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

Life-expectancy of patients enrolled in phase 1 clinical trials: a systematic review of published prognostic models.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

Patient selection for oncology phase I trials: a multi-institutional study of prognostic factors.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

Prospective validation of a prognostic score to improve patient selection for oncology phase I trials

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

The Cancer Therapy Evaluation Program (CTEP) at the National Cancer Institute: industry collaborations in new agent development.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3918535

90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial?

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24419130

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden Hospital

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24419130

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Performing phase I clinical trials of anticancer agents: perspectives from within the European union and Japan

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24419130

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2013.49.8808

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24419130

1 reference